Longmont, Colo.-based Acertara, an International Organization for Standardization 13485:2003 certified probe repair and new product development facility, announces that its research and development team has been awarded U.S. patent No. 9,696,356 for a device and method of testing ultrasound probes.

Commenting on the new patent, G. Wayne Moore, president and CEO of Acertara, says: “This patent represents the 25th patent our team has been awarded relative to diagnostic ultrasound system and probe testing devices.” In fact, he reveals, the company’s engineering team first developed the modern ultrasound probe testing model more than 17 years ago when it introduced FirstCall at Sonora Medical Systems.

“Continuing that legacy at Acertara has led to the development of several important new probe-testing devices, including Aureon and ATLAS, which have continued to pave the way for our advanced probe repair capabilities,” Moore adds.

The R&D team at Acertara Acoustic Laboratories has been awarded more than 45 U.S. and international patents, ranging from 3D ultrasound products to devices that deliver super-saturated levels of oxygen to myocardial tissue of heart attack patients.